Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy, Intensity-Modulated | 11 | 2021 | 801 | 2.340 |
Why?
|
| Organs at Risk | 11 | 2021 | 359 | 2.310 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 18 | 2024 | 1661 | 1.420 |
Why?
|
| Neoplasms, Radiation-Induced | 6 | 2015 | 549 | 0.930 |
Why?
|
| Radiotherapy Dosage | 13 | 2021 | 2898 | 0.730 |
Why?
|
| Radiometry | 5 | 2016 | 813 | 0.720 |
Why?
|
| Protons | 6 | 2021 | 1115 | 0.540 |
Why?
|
| Prostatic Neoplasms | 8 | 2021 | 11116 | 0.490 |
Why?
|
| Monte Carlo Method | 5 | 2016 | 1257 | 0.450 |
Why?
|
| Radiation Dosage | 3 | 2015 | 1958 | 0.400 |
Why?
|
| Neutrons | 1 | 2012 | 77 | 0.390 |
Why?
|
| Phantoms, Imaging | 5 | 2016 | 2524 | 0.380 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 90 | 0.360 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2015 | 474 | 0.350 |
Why?
|
| Gamma Rays | 1 | 2011 | 318 | 0.330 |
Why?
|
| Neoplasms, Second Primary | 2 | 2015 | 1051 | 0.330 |
Why?
|
| Radiation Injuries | 1 | 2015 | 1189 | 0.310 |
Why?
|
| Relative Biological Effectiveness | 4 | 2017 | 312 | 0.290 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4321 | 0.260 |
Why?
|
| Rectum | 4 | 2017 | 892 | 0.230 |
Why?
|
| Pelvic Neoplasms | 2 | 2015 | 247 | 0.220 |
Why?
|
| Thoracic Neoplasms | 2 | 2015 | 266 | 0.210 |
Why?
|
| Sarcoma | 2 | 2024 | 1793 | 0.190 |
Why?
|
| Positron-Emission Tomography | 2 | 2024 | 6478 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2024 | 36430 | 0.190 |
Why?
|
| Particle Accelerators | 1 | 2021 | 174 | 0.180 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 9030 | 0.170 |
Why?
|
| Movement | 2 | 2015 | 1478 | 0.150 |
Why?
|
| Tumor Burden | 1 | 2024 | 1887 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8997 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 4 | 2015 | 2891 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2024 | 1156 | 0.130 |
Why?
|
| Seminal Vesicles | 1 | 2015 | 103 | 0.130 |
Why?
|
| Scattering, Radiation | 2 | 2014 | 490 | 0.130 |
Why?
|
| Normal Distribution | 1 | 2015 | 272 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 2009 | 0.120 |
Why?
|
| Urinary Bladder | 3 | 2016 | 1150 | 0.120 |
Why?
|
| Uncertainty | 3 | 2015 | 754 | 0.120 |
Why?
|
| Fiducial Markers | 1 | 2015 | 132 | 0.120 |
Why?
|
| Neoplasms | 4 | 2015 | 22158 | 0.110 |
Why?
|
| Radiotherapy, Conformal | 1 | 2015 | 548 | 0.100 |
Why?
|
| Calibration | 1 | 2015 | 818 | 0.100 |
Why?
|
| Photons | 2 | 2015 | 589 | 0.100 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 358 | 0.100 |
Why?
|
| Male | 18 | 2024 | 360621 | 0.090 |
Why?
|
| Seminoma | 1 | 2012 | 134 | 0.090 |
Why?
|
| Organ Size | 1 | 2015 | 2252 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 2853 | 0.090 |
Why?
|
| Humans | 24 | 2024 | 761326 | 0.080 |
Why?
|
| Fetus | 1 | 2015 | 1864 | 0.080 |
Why?
|
| Respiration | 1 | 2014 | 1657 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
| Observer Variation | 2 | 2024 | 2605 | 0.070 |
Why?
|
| Testicular Neoplasms | 1 | 2012 | 799 | 0.060 |
Why?
|
| Body Height | 1 | 2012 | 1570 | 0.060 |
Why?
|
| Radiotherapy | 1 | 2012 | 1499 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2015 | 23981 | 0.060 |
Why?
|
| Radiography | 1 | 2015 | 6966 | 0.060 |
Why?
|
| Child | 5 | 2015 | 80156 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2014 | 6236 | 0.060 |
Why?
|
| Linear Energy Transfer | 2 | 2016 | 152 | 0.050 |
Why?
|
| Body Weight | 1 | 2012 | 4614 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5247 | 0.040 |
Why?
|
| Online Systems | 1 | 2020 | 182 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 20555 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2015 | 42251 | 0.040 |
Why?
|
| Female | 9 | 2024 | 392485 | 0.040 |
Why?
|
| Software | 1 | 2011 | 4439 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 851 | 0.030 |
Why?
|
| Penis | 1 | 2016 | 212 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 220774 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 20092 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 14025 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2015 | 54405 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 2650 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 41440 | 0.030 |
Why?
|
| Infant | 2 | 2015 | 36202 | 0.030 |
Why?
|
| Adolescent | 4 | 2015 | 88305 | 0.030 |
Why?
|
| Optic Nerve Glioma | 1 | 2012 | 32 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26211 | 0.020 |
Why?
|
| Pelvis | 1 | 2016 | 732 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 882 | 0.020 |
Why?
|
| Probability | 1 | 2015 | 2478 | 0.020 |
Why?
|
| Water | 1 | 2016 | 1410 | 0.020 |
Why?
|
| Aged | 2 | 2024 | 169179 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 1272 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2015 | 5078 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 80575 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2012 | 1784 | 0.020 |
Why?
|
| Adult | 3 | 2024 | 221122 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11098 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29858 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13333 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21009 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 27103 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 74152 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_